This ADC product is composed of an anti-EGFRvIII antibody conjuagated via a Mcc linker to DM1 (anti-EGFRvIII antibody-mcc-DM1). It has demonstrated a response in Glioblastoma treatment by a MOA (Mechanism of Action) of Depolymerize Microtubules.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For research use only. Not intended for any clinical use.